explore -WSS

explore

author：comprehensive 2025-09-29 21:20:52 - browse：4

Matts Take Column Illustration — Molly Ferguson for STAT

American medicine is a tragic paradox. An example: Cancer patients are likely dying as a result of drug shortages that occurred partly because generic chemotherapies have been allowed to become too cheap. At the same time, other patients are suffering, and perhaps dying, because the financial burden brought on by the expensive medicines they need is too high.

Sit with that like a terrible Zen koan: Medicines are both too cheap and too expensive.

How is that possible? A lot of it goes back to the 1984 Hatch-Waxman Act, which set up the ecosystem that determines the process by which drugs go from being expensive brands to cheap generics in the U.S.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Why Medicare shouldn’t cover every FDA

hotspot

WSS

Biogen walks away from Aduhelm, years after polarizing approval

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

FDA approves RSV monoclonal antibody for infants, toddlers

Doctors find melanoma drugs effective against rare brain cancer

Humana’s losses in Medicare Advantage tank its stock

Biogen walks away from Aduhelm, years after polarizing approval

Wikipedia

explore

focus

Trump demands the U.S. pay no more for drugs than other countries … again

At Orexo, a ‘turning point’ for everything but digital health

In age of alternative facts, a scholarly course on calling out crap

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Psychedelics group wrestles with new pharma identity

How Medicaid coverage policies for immigrants impact new moms

In age of alternative facts, a scholarly course on calling out crap

How dance can help nurses traumatized by Covid

Peter Hotez and the public health issue of online harassment

Medicare drug price negotiation legal challenge met with skepticism

entertainment

Merck, Johnson & Johnson CEOs will testify on high drug prices

Humana’s losses in Medicare Advantage tank its stock

Boston competes with Raleigh

Sanders adds drug shortage policies to pandemic preparedness bill

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Venture capital firm's plans to take over Akron hospital face hurdles

focus

hotspot

hotspot

hotspot